Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-27T02:59:57.757Z Has data issue: false hasContentIssue false
  • English
  • Français

Hearing status in patients with rheumatoid arthritis

Published online by Cambridge University Press:  15 August 2017

A Ahmadzadeh ,
M Daraei ,
M Jalessi ,
A A Peyvandi ,
E Amini ,
L A Ranjbar  and
A Daneshi
A Ahmadzadeh
Affiliation:
Hearing Disorders Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
M Daraei
Affiliation:
Hearing Disorders Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
M Jalessi
Affiliation:
Skull Base Research Center, Hazrat Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
A A Peyvandi
Affiliation:
Clinical Research Development Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
E Amini*
Affiliation:
Skull Base Research Center, Hazrat Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran ENT and Head and Neck Research Center and Department, Hazrat Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
L A Ranjbar
Affiliation:
Hearing Disorders Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
A Daneshi
Affiliation:
ENT and Head and Neck Research Center and Department, Hazrat Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
*
Address for correspondence: Dr Elahe Amini, Skull Base Research Center, ENT and Head and Neck Research Center and Department, Hazrat Rasoul Akram Hospital, Niayesh St, Sattar Khan Ave, Tehran, Iran Fax: +98 216 652 5329 E-mail: elaheaminimd@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

Rheumatoid arthritis is thought to induce conductive hearing loss and/or sensorineural hearing loss. This study evaluated the function of the middle ear and cochlea, and the related factors.

Methods:

Pure tone audiometry, speech reception thresholds, speech discrimination scores, tympanometry, acoustic reflexes, and distortion product otoacoustic emissions were assessed in rheumatoid arthritis patients and healthy volunteers.

Results:

Pure tone audiometry results revealed a higher bone conduction threshold in the rheumatoid arthritis group, but there was no significant difference when evaluated according to the sensorineural hearing loss definition. Distortion product otoacoustic emissions related prevalence of conductive or mixed hearing loss, tympanometry values, acoustic reflexes, and speech discrimination scores were not significantly different between the two groups. Sensorineural hearing loss was significantly more prevalent in patients who used azathioprine, cyclosporine and etanercept.

Conclusion:

Higher bone conduction thresholds in some frequencies were detected in rheumatoid arthritis patients that were not clinically significant. Sensorineural hearing loss is significantly more prevalent in refractory rheumatoid arthritis patients.

Keywords

Rheumatoid ArthritisHearing LossAudiometryCochlea
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 131 , Issue 10 , October 2017 , pp. 895 - 899
Copyright
Copyright © JLO (1984) Limited 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Alamanos, Y, Drosos, AA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 2005;4:130–6CrossRefGoogle ScholarPubMed
2 Mueller, RB, Schiff, M, Kaegi, T, Finckh, A, Haile, SR, Schulze-Koops, H et al. The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis. Clin Rheumatol 2015;34:51–9Google Scholar
3 Turesson, C, O'Fallon, W, Crowson, C, Gabriel, S, Matteson, E. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003;62:722–7CrossRefGoogle ScholarPubMed
4 Copeman, WS. Rheumatoid oto-arthritis. Br Med J 1963;2:1526–7Google Scholar
5 Rosenberg, JN, Moffat, DA, Ramsden, RT, Gibson, WP, Booth, JB. Middle ear function in rheumatoid arthritis. Ann Rheum Dis 1978;37:522–4Google Scholar
6 Ozcan, M, Karakus, MF, Gunduz, OH, Tuncel, U, Sahin, H. Hearing loss and middle ear involvement in rheumatoid arthritis. Rheumatol Int 2002;22:16–19 Google ScholarPubMed
7 Ozturk, A, Yalcin, S, Kaygusuz, I, Sahin, S, Gok, U, Karlidag, T et al. High-frequency hearing loss and middle ear involvement in rheumatoid arthritis. Am J Otolaryngol 2004;25:411–17Google Scholar
8 Goodwill, CJ, Lord, IJ, Jones, RP. Hearing in rheumatoid arthritis. A clinical and audiometric survey. Ann Rheum Dis 1972;31:170–3Google ScholarPubMed
9 American Speech-Language-Hearing Association Committee on Audiometric Evaluation. Guidelines for manual pure-tone threshold audiometry. ASHA 1978;20:297–301 Google Scholar
10 Mathers, C, Smith, A, Concha, M. Global Burden of Hearing Loss in the Year 2000. Global Burden of Disease. Geneva: World Health Organization, 2003;1–30 Google Scholar
11 Siamopoulou-Mavridou, A, Asimakopoulos, D, Mavridis, A, Skevas, A, Moutsopoulos, HM. Middle ear function in patients with juvenile chronic arthritis. Ann Rheum Dis 1990;49:620–3CrossRefGoogle ScholarPubMed
12 Campos Ude, P, Carvallo, RM. Correlation between DPOAE I/O functions and pure-tone thresholds. Braz J Otorhinolaryngol 2011;77:754–60Google ScholarPubMed
13 Dikici, O, Muluk, NB, Tosun, AK, Unlusoy, I. Subjective audiological tests and transient evoked otoacoustic emissions in patients with rheumatoid arthritis: analysis of the factors affecting hearing levels. Eur Arch Otorhinolaryngol 2009;266:1719–26CrossRefGoogle ScholarPubMed
14 Murdin, L, Patel, S, Walmsley, J, Yeoh, LH. Hearing difficulties are common in patients with rheumatoid arthritis. Clin Rheumatol 2008;27:637–40CrossRefGoogle ScholarPubMed
15 Simopoulos, A. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 2006;60:502–7Google Scholar
16 Jamshidi, AR, Tehrani Banihashemi, A, Roknsharifi, S, Akhlaghi, M, Salimzadeh, A, Davatchi, F. Estimating the prevalence and disease characteristics of rheumatoid arthritis in Tehran: a WHO -ILAR COPCORD Study (from Iran COPCORD study, Urban Study stage 1). Med J Islam Repub Iran 2014;28:93 Google Scholar
17 Alishiri, GH, Salimzadeh, A, Owlia, MB, Forghanizadeh, J, Setarehshenas, R, Shayanfar, N. Prevalence of amyloid deposition in long standing rheumatoid arthritis in Iranian patients by abdominal subcutaneous fat biopsy and assessment of clinical and laboratory characteristics. BMC Musculoskelet Disord 2006;7:43 Google Scholar
18 Trevino-Gonzalez, JL, Villegas-Gonzalez, MJ, Munoz-Maldonado, GE, Montero-Cantu, CA, Nava-Zavala, AH, Garza-Elizondo, MA. Subclinical sensorineural hearing loss in female patients with rheumatoid arthritis [in Spanish]. Cir Cir 2015;83:364–70Google ScholarPubMed
19 Ozkiris, M, Kapusuz, Z, Gunaydin, I, Kubilay, U, Pirti, I, Saydam, L. Does rheumatoid arthritis have an effect on audiovestibular tests? Eur Arch Otorhinolaryngol 2014;271:1383–7CrossRefGoogle ScholarPubMed
20 Bortoli, R, Santiago, M. Chloroquine ototoxicity. Clin Rheumatol 2007;26:1809–10CrossRefGoogle ScholarPubMed
21 Pascual-Ramos, V, Contreras-Yanez, I, Rivera-Hoyos, P, Enriquez, L, Ramirez-Anguiano, J. Cumulative disease activity predicts incidental hearing impairment in patients with rheumatoid arthritis (RA). Clin Rheumatol 2014;33:315–21Google Scholar
22 Gorga, M, Neely, S, Bergman, B, Beauchaine, K, Kaminski, J, Peters, J et al. Otoacoustic emissions from normal-hearing and hearing-impaired subjects: distortion product responses. J Acoust Soc Am 1993;93:2050–60Google Scholar
23 Gorga, M, Neely, S, Darn, P. Distortion product otoacoustic emission test performance for a priori criteria and for multifrequency audiometric standards. Ear Hear 1999;20:345–62CrossRefGoogle ScholarPubMed
24 Gorga, M, Nelson, K, Davis, T, Darn, P, Neely, S. Distortion product otoacoustic emission test performance when both 2f1-f2 and 2f2-fl are used to predict auditory status. J Acoust Soc Am 2000;107:2128–35CrossRefGoogle ScholarPubMed
25 Norton, S, Gorga, M, Widen, J, Folsom, R, Sininger, Y, Cone-Wesson, B et al. Identification of neonatal hearing impairment: evaluation of transient evoked otoacoustic emission, distortion product otoacoustic emission, and auditory brain stem response test performance. Ear Hear 2000;21:508–28Google Scholar
26 Dagli, M, Sivas Acar, F, Karabulut, H, Eryilmaz, A, Erkol Inal, E. Evaluation of hearing and cochlear function by DPOAE and audiometric tests in patients with ankylosing spondilitis. Rheumatol Int 2007;27:511–16Google Scholar
27 Drexl, M, Faulstich, M, von Stebut, B, Radtke-Schuller, S, Kössl, M. Distortion product otoacoustic emissions and auditory evoked potentials in the hedgehog tenrec, Echinops telfairi. J Assoc Res Otolaryngol 2003;4:555–64Google Scholar
28 Brown, AM, Kemp, DT. Suppressibility of the 2fl−f2 stimulated acoustic emissions in gerbil and man. Hear Res 1984;13:29–37 Google Scholar
29 Jenkinson, PW, Syed, MI, McClymont, L. Progressive, reversible sensorineural hearing loss caused by azathioprine. J Laryngol Otol 2014;128:838–40Google Scholar
30 Wang, X, Truong, T, Billings, PB, Harris, JP, Keithley, EM. Blockage of immune-mediated inner ear damage by etanercept. Otol Neurotol 2003;24:52–7CrossRefGoogle ScholarPubMed
31 McClelland, L, Powell, RJ, Birchall, J. Role of ciclosporin in steroid-responsive sudden sensorineural hearing loss. Acta Otolaryngol 2005;125:1356–60Google Scholar
32 Fransen, J, Van Riel, P. The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol 2005;23(5 suppl 39):S93–9Google Scholar